Latest News

Left Right
Honor for Dimension Research CEO.. The CEO of Dimension Research Mr. Khurram Zaki Khan will be managing a unique certificate program on ICH-GCP at IBA, City Center as trainer. ISO-Certificate_Page_1This 10 weeks weekend program will be commencing on 20th July 2016 in collaboration with Center of Executive Education ,IBA. The program is developed to cater the needs of the personnel planning to join or working at Pharmaceutical Industry Medical /Research wing or be part of Clinical Research team in Pharmaceutical, Research, NGO and Academia nationally or internationally.

This certificate program will strengthen the efforts of IBA to elevate the Health Care Industry and Institutions standards of Pakistan and prepare them to be part of the international research activities.

The program is highly recommended for :

  • MD/ MBBS
  • Pharmacist
  • B.Sc/ B.Sc Honors
  • M.Sc
  • M.Phil/ PhD
  • Registered Nurse
  • Computer Sciences
  • Economics
  • Allied Health Sciences
Dimension Research® SMO & CRO is now the only Clinical Research Organization of Pakistan having ISO 9001:2008 certificate issued by Lloyd’s, U.K. for the following services:.

  • Develop and Manage Pre-Clinical & Clinical Research
  • Site Management
  • Database Development
  • Data Management
  • Statistical Analysis
  • Adverse Drug Reaction Reporting System (ADR)
  • Patient Support Services
  • Provide Research and Soft Skills trainings to their customers.

ISO-Certificate_Page_1This is part of our continuous development program to provide our customers standardized services in all the dimensions in research and related areas.

First Training On Adverse Drug Reaction (ADR) reporting system at LUMHS), Jamshoro, Hyderabad.

First Training On Adverse Drug Reaction (ADR) reporting system at LUMHS), Jamshoro, Hyderabad.

Training on ADR reporting system was given on Thursday, 2nd of April, 2015, to the first batch of Healthcare Professionals (HCPs) at Liaquat University of Medical & Health Sciences (LUMHS), Jamshoro, Hyderabad.

Dr. Taha Inam, Manager, Medical & Pharmacovigilance (PhV) went to Hyderabad on two day visit to provide this training.

Dr. Suleman Pirzado organized the training who is In-Charge of the ADR reporting Unit of LUMHS and Head of Molecular Biology at Medical Research Center (MRC), LUMHS.

Total 20 participants attended the training from departments of Surgery Allied, Orthopedics, Pediatrics, Obstetrics & Gynecology, and Dermatology.  A mixed attendance comprise of the medical and paramedical staff with doctors (Assistant Professors, Senior Resident Officers, Postgraduate Students, Medical Officers) and paramedics (Staff and Senior Nurses and Technicians).

Training went well and ADR reporting forms were distributed next day to all the trained HCPs at their respective department to start collecting the ADRs and Adverse and Serious Adverse Events (AEs/SAEs).

Dimension Development Foundation, DDF, takes over the ‘Adverse Drug Reaction’ reporting services from DIMENSION REAERSCH, CRO.


Dr. Taha Inam, Manager, Medical & PhV, Dimension Research CRO

The services of Adverse Drug Reaction (ADR) reporting system which was established by Dimension Research (DR) CRO of Pakistan in 2013 has been taken over by (i) Dimension Development Foundation (DDF).

ADR reporting is a missed and neglected area in the healthcare industry of Pakistan, not proving the unsolicited ADRs and Adverse Events (AEs) produced by the pharmaceutical products in Pakistani human/sick population after the administration of prescribed or over the counter (OTC) medicinal product(s).

With effect of September 2014, DDF has the responsibility of collection, cleaning and reporting of the ADRs from multiple public and private health care service institutes.

DDF will also be responsible for the electronic data feeding of all collected ADRs, AEs including serious AEs (SAEs) in the (ii) web-based software, developed by Dimension Research CRO working voluntary throughout Pakistan. is easily accessible with registration free of charge like a Facebook or Twitter account. The users can enter the ADRs/AEs/SAEs which they or their relatives experiences with the pharmaceutical products.

Please note that in June 2014 Drug Regulatory Authority of Pakistan (DRAP) has issued a letter/notification to all the national and multinational pharmaceutical companies to submit report(s) of the ADRs of their distributed products from all over Pakistan to DRAP every month.

Relevant links:



MoU signed between Dimension Research (DR) CRO and Dadabhoy Institute of Higher Education (DIHE).

Exciting news:

Last Saturday on 7 February 2015, another Memorandum of Understanding – MoU has been signed in between thumb_news1_ddbDadabhoy Institute of Higher Education (DIHE) and Dimension Research (DR). The programs under this MoU are the training programs of short course Selling skills and long course Clinical Research Certificate Program offered by the DR expert professionals.

thumb_news2_ddbThe signatories from both the parties were the Vice Chancellor of DIHE, Prof. Dr. Shahana Urooj Kazmi and CEO of DR Mr. Khurram Zaki Khan. Snaps below shows the faculty members of DIHE also.

“Dimension Research, the ‘National Coordinator’ for Oxford University, UK”

oxfordbanner DCVAS; Development of new Diagnostic and Classification criteria of Primary Systemic Vasculitis. Dimension Research became the National Coordinator of Oxford University of United Kingdom, for the management of its global study being conducted in more than 120 study sites in 40 countries. oxfordPakistan is now taking part with its nationwide sites for the enrollment of study subjects suffering from Primary Systemic Vasculitis.

EXPLORING SINDH: LUMHS; Liaquat University of Medical & Health Sciences, Jamshoro,


DR has credibility of having joint ventures with leading academia of Pakistan. In the year 2014, DR got the opportunity to develop joint venture partnership with one of the nation’s largest medical university, Liaquat University of Medical & Health Sciences (LUMHS), Jamshoro, Hyderabad, Sindh.

Clinical studies already initiated in December 2014 at Medical Research Centre/Clinical Trial Unit of LUMHS. Multiple clinical research proposals are to be signed soon.

FOUNDING OF AN INNOVATIVE NGO; Dimension Development Foundation

ddf_banner With experience of clinical research in both private and government sector, DR realized the need for access and provision of the clinical and health services to the common public of Pakistan. This in turn developed a thought to cover all the aspects of a Non-for-Profit-Non-Government-Organization, NGO, which can support and deliver the services in the areas of not only health, but education, social and environmental requirements of the nation through dedicated and qualified professionals. Dimension Development Foundation got its registration late last year and soon to start its projects in first quarter of 2015.

DRAP concern for ADRs

DRAP-Logo-copyDrug Regulatory Authority of Pakistan issued a letter in June, 2014, (No. F.’l’1 /201 4-DDG(PV), to both national and multinational Pharmaceutical companies, asking them to submit their respective products’ Adverse Drug Reactions (ADRs). All the pharma companies distributing their products in Pakistani market are advised to report their collected ADRs as a routine on 15th day of every month. When there is no ADR, they have to report as ‘No ADR reported’. This is a positive step by DRAP to promote safe and appropriate usage of the medicines with having their vigilance reported, hence assuring the patient safety in the Pakistani population.

Good News for Pakistani Exporters of Medical & Surgical instruments to USA!!

US Food & Drugs Adminsitration, FDA, Exempts the Pakistani firms (manufacturing surgical & medical instruments), from “Detention Without Physical Examination”, after getting compliance verification by Third party “Quality System Audit & Regulation Program”

DETAILS: U.S. Food & Drug Administration

Import Alert 76-01                                    Report by: Dr. Taha Inam

Import Alert # 76-01

Published Date: 19/May/2014

Type: DWPE; (Detention Without Physical Examination)

Import Alert Name: “Detention Without Physical Examination Of Medical Instruments from Pakistan”


Dimension Research®- New Head Office

dr_office_thumbnailDimension Research® has shifted its Head Office in Karachi to a new custom made 7000 sq. ft. facility. This new head office includes specially designed Training & Conference room, Archiving facility and office space to cover the growing requirements of the expanding business. This milestone has been achieved within three years of successful business operations.

Dimension Research’s management likes to forward their gratitude to our honorable customers for their continuous support and our dedicated employees whose effort has materialized this milestone in a short span of time after company establishment.

Visit Us On TwitterVisit Us On FacebookVisit Us On Linkedin